3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
2
Recruiting
1
Sponsor Class
OTHER
3
Study Type
Observational
3
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Genitourinary
1
Breast
1
Conditions
Drug-Related Side Effects and Adverse Reactions
2
Cardiovascular Diseases
2
Cardiotoxicity
2
Prostatic Neoplasms
1
Neoplasm Metastasis
1
Breast Neoplasms
1
Interventions
Surveys and Questionnaires
529
Blood Specimen Collection
406
Surgical Procedures, Operative
152
Radiotherapy
131
Interviews as Topic
131
Drug Therapy
123
Observation
122
Magnetic Resonance Spectroscopy
104
Biopsy
103
Specimen Handling
70
Data Collection
70
Neoadjuvant Therapy
65
Immunohistochemistry
64
Magnetic Resonance Imaging
61
Immune Checkpoint Inhibitors
59
Watchful Waiting
52
Immunotherapy
51
Bevacizumab
50
Positron Emission Tomography Computed Tomography
46
Ultrasonography
44
Hematologic Tests
42
Liquid Biopsy
41
Tomography, X-Ray Computed
40
Therapeutics
40
Radiosurgery
40
Colonoscopy
40
pembrolizumab
37
Hepatectomy
37
Gene Expression Profiling
36
High-Energy Shock Waves
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
Observational
×
Social Determinants of Health
×
Clear all
NCT05096338
2026-03-23
PCT
Abramson Cancer Center at Penn Medicine
Active not recruiting
200 enrolled
NCT05078190
2025-11-06
CCT2
Abramson Cancer Center at Penn Medicine
Active not recruiting
200 enrolled
NCT06081517
2025-06-13
EDPO
Indiana University
Recruiting
10,600 enrolled